Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
US Department of Justice
Chubb
UBS
Harvard Business School
Queensland Health
Merck
Moodys
Argus Health

Generated: April 22, 2018

DrugPatentWatch Database Preview

DRALSERP Drug Profile

« Back to Dashboard

Which patents cover Dralserp, and what generic alternatives are available?

Dralserp is a drug marketed by Sandoz and is included in one NDA.

The generic ingredient in DRALSERP is hydralazine hydrochloride; reserpine. There are twenty drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; reserpine profile page.
Summary for DRALSERP
Drug patent expirations by year for DRALSERP

US Patents and Regulatory Information for DRALSERP

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz DRALSERP hydralazine hydrochloride; reserpine TABLET;ORAL 084617-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
UBS
Merck
Cerilliant
Express Scripts
Farmers Insurance
Queensland Health
Deloitte
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.